Parallel Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19
| Closed | – | – | 3657 |
|
|
2024
Q3 | $0 | Hold |
19
| – | – | ﹤0.01% | 3516 |
|
|
2024
Q2 | $816 | Buy |
+19
| New | +$807 | ﹤0.01% | 3007 |
|
|
2023
Q4 | – | Sell |
-22
| Closed | -$830 | – | 3504 |
|
|
2023
Q3 | $830 | Hold |
22
| – | – | ﹤0.01% | 3006 |
|
|
2023
Q2 | $834 | Sell |
22
-41
| -65% | -$1.29K | ﹤0.01% | 2977 |
|
|
2023
Q1 | $1.53K | Sell |
63
-151
| -71% | -$4.4K | ﹤0.01% | 2846 |
|
|
2022
Q4 | $6.21K | Buy |
214
+74
| +53% | +$2.19K | ﹤0.01% | 2234 |
|
|
2022
Q3 | $4K | Buy |
+140
| New | +$4.83K | ﹤0.01% | 2432 |
|
|
2022
Q2 | – | Sell |
-183
| Closed | -$8K | – | 3439 |
|
|
2022
Q1 | $8K | Sell |
183
-225
| -55% | -$10.5K | ﹤0.01% | 2143 |
|
|
2021
Q4 | $20K | Buy |
408
+347
| +569% | +$19.4K | ﹤0.01% | 1800 |
|
|
2021
Q3 | $4K | Buy |
61
+23
| +61% | +$1.59K | ﹤0.01% | 2518 |
|
|
2021
Q2 | $3K | Hold |
38
| – | – | ﹤0.01% | 2510 |
|
|
2021
Q1 | $3K | Hold |
38
| – | – | ﹤0.01% | 2423 |
|
|
2020
Q4 | $3K | Buy |
38
+4
| +12% | +$257 | ﹤0.01% | 2243 |
|
|
2020
Q3 | $2K | Sell |
34
-22
| -39% | -$1.37K | ﹤0.01% | 2370 |
|
|
2020
Q2 | $3K | Sell |
56
-67
| -54% | -$4.49K | ﹤0.01% | 2142 |
|
|
2020
Q1 | $7K | Buy |
123
+94
| +324% | +$6.96K | ﹤0.01% | 1795 |
|
|
2019
Q4 | $3K | Sell |
29
-108
| -79% | -$9.11K | ﹤0.01% | 2151 |
|
|
2019
Q3 | $10K | Buy |
+137
| New | +$11.1K | ﹤0.01% | 1693 |
|
|
2019
Q2 | – | Sell |
-4
| Closed | – | – | 2465 |
|
|
2019
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 2422 |
|
|
2018
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 2327 |
|
|
2018
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 2318 |
|
|
2018
Q2 | $0 | Sell |
4
-21
| -84% | -$2.31K | ﹤0.01% | 2228 |
|
|
2018
Q1 | $2K | Sell |
25
-5
| -17% | -$507 | ﹤0.01% | 1905 |
|
|
2017
Q4 | $3K | Sell |
30
-7
| -19% | -$769 | ﹤0.01% | 1784 |
|
|
2017
Q3 | $4K | Sell |
37
-11
| -23% | -$1.2K | ﹤0.01% | 1702 |
|
|
2017
Q2 | $5K | Sell |
48
-41
| -46% | -$4.63K | ﹤0.01% | 1625 |
|
|
2017
Q1 | $10K | Buy |
89
+53
| +147% | +$5.87K | ﹤0.01% | 1245 |
|
|
2016
Q4 | $4K | Buy |
+36
| New | +$3.77K | ﹤0.01% | 1474 |
|
Other funds holding TARO
Parallel Advisors's TARO Position: Q4 2024 in Review
Parallel Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2024, closing a stake of 19 shares.
Parallel Advisors first reported a position in TARO in Q4 2016 and held it in 28 quarters. The position peaked at $20K in Q4 2021. 3 funds tracked by Wall St. Rank hold TARO as of Q4 2024.
- Parallel Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2024 after selling out during the quarter.
- Parallel Advisors sold 19 Taro Pharmaceutical Industries Ltd. shares in Q4 2024.
- Parallel Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2016 and held it in 28 quarters.
- Parallel Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $20K in Q4 2021.
- 3 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2024.
Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.